Bipolar disorder (BD) is a chronic mental disease that substantially affects the patient’s quality of life and causes significant morbidity and mortality. Although there are a variety of available treatments, therapeutic intervention is not beneficial in many cases and recurrence rates remain high. Recent data suggested tamoxifen, a drug with a wide range of activities, as a potential treatment for reducing manic symptoms of BD. Tamoxifen’s therapeutic effect on bipolar mania has not been fully elucidated, but it is believed to biochemically operate on protein kinase C (PKC) inhibition. In this article, we review preclinical and clinical studies investigating the efficacy of tamoxifen as a potential treatment for bipolar manic patients.
CITATION STYLE
Bagdadi, N., Azab, A. N., & Shvartsur, R. (2021). The Use of Tamoxifen as a Potential Treatment for Bipolar Disorder. Psychiatry and Clinical Psychopharmacology, 31(3), 344–352. https://doi.org/10.5152/pcp.2021.21817
Mendeley helps you to discover research relevant for your work.